2013年5月31日

第3天冷凍胚胎植入比第2天懷孕率較高

第3天胚胎冷凍解凍植入FET比第2天胚胎冷凍解凍植入懷孕率較高 (17 vs 4%)

http://www.ncbi.nlm.nih.gov/pubmed/23965660



 2013 Aug 22:1-8. [Epub ahead of print]

Vitrification of day 3 cleavage-stage embryos yields better clinical outcome in comparison withvitrification of day 2 cleavage-stage embryos.

Source

IVF Program, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Abstract

Summary The objective of this retrospective study was to determine an optimal time point for vitrification of cleavage-stage human embryos. This study included patients who were undergoing day 2 or day 3 vitrified-warmed cleavage-stage embryotransfer at the In Vitro Fertilization (IVF) Programme of the Shanghai First Maternity and Infant Hospital, China, affiliated to the Tongji University School of Medicine, from April 2010 to March 2012. Intervention was made for the entire cohort of vitrified embryos for poor responder patients so as to avoid severe ovarian hyperstimulation syndrome. Embryo survival rate (SR) aftervitrification-warming, implantation rate (IR), and clinical pregnancy rate (CPR) were the main outcome measurements. In total, 380 vitrified-warmed cleavage-stage embryo transfer (VWT) cycles were included. We found that the SR after vitrification and warming for day 2 embryos and day 3 embryos were 92.7% and 92.8%, respectively. For poor ovarian responders, the IR of day 2 and day 3 vitrified-warmed embryos was 6.4% and 13.2%, respectively (P = 0.186). The CPR for day 3 vitrified-warmed embryos was significantly higher than that of day 2 vitrified-warmed embryos (17.6 vs. 4.0 % per transfer cycle, P = 0.036). For patients who had their entire cohort of embryos vitrified to prevent severe ovarian hyperstimulation syndrome (OHSS), the IR and CPR were not significantly different for day 2 and day 3 vitrified-warmed embryo transfer. In conclusion, for vitrified-warmed embryo transfer, cryopreservation of the entire cohort of embryos on day 3 resulted in better clinical outcomes compared with cryopreservation on day 2. Therefore, it is highly recommended that cleavage-stage embryos should be vitrified on day 3, but not on day 2, particularly for poor ovarian responder patients.

沒有留言:

張貼留言